PARLIAMENTARY DEBATE
Covid-19: International Response - 6 May 2020 (Commons/Commons Chamber)
Debate Detail
The world is now having to address the biggest threat that it has faced in decades: an invisible killer on a global scale. Here in the UK, communities across the country are united in their determination to beat it, making their own personal sacrifices by staying at home, protecting our NHS and saving lives.
There is a daunting outlook for countries in the developing world, simultaneously facing a health crisis, a humanitarian crisis and the risk of a protracted economic crisis leading to much greater hardship for years to come. The threat of famines, exacerbated by the worst locust plague for 70 years, fragile healthcare systems that enable the spread of the disease and economic disruptions risk a much longer and harder road back to recovery than for wealthy countries.
However, through the altruism of the British people and the expertise of our scientists and engineers, the UK is proudly playing a leading role in the global response. On Monday, together with other world leaders, my right hon. Friend the Prime Minister co-hosted a virtual global coronavirus response pledging conference. He called on countries around the world to step up their efforts and work together on this, the
“most urgent shared endeavour of our lifetimes”.
World leaders responded, and some £6.5 billion was pledged for the covid-19 response, including the UK’s own £388 million commitment for vaccines, tests and treatments. The UK is proud to stand with our international partners—this is a truly global effort, and the only way to fight this pandemic is together.
The UK is a development superpower, and we are also a scientific and medical world leader. This enables our response to this global pandemic to be greater than the sum of its parts. From Gloucestershire’s Dr Edward Jenner, who laid the foundations for immunology, to our researchers who developed vaccines for measles and Ebola, the UK has led the scientific response to many global health challenges in the past. I am so proud to be able to say that UK-based scientists, such as those at the Liverpool School of Tropical Medicine, are playing key roles in the global response to this deadly new virus. Scientists in Bedfordshire who developed rapid diagnostic devices to manage the recent Ebola outbreak, funded with taxpayers’ money through UK aid, are using that expertise to develop new rapid diagnostic tests.
Researchers at Oxford University, funded through CEPI— the Coalition for Epidemic Preparedness Innovations —are now progressing to clinical trials, with funding from the UK Government’s vaccines taskforce, which is also funding a vaccine trial starting soon at Imperial College. In partnership with a British success story, AstraZeneca—one of the world’s largest pharmaceutical companies—our Oxford researchers are working towards their vaccine being manufactured at scale. We know that any vaccine might prove to be the solution, so through our Department for International Development aid budget, the UK is the largest single contributor of any country to CEPI’s international efforts to find a coronavirus vaccine. Through this fund, we are working to improve our understanding of the virus and to support scientists around the globe. CEPI is already backing nine potential vaccines.
The Foreign Secretary outlined at the launch of the World Health Organisation’s access to covid-19 tools accelerator that the UK is proud to work with our international partners to ensure that new vaccines are accessible to everyone, as quickly as possible. No one will be safe until we are all safe. So we will need vaccines against this deadly disease, at home and abroad. Once a vaccine is found, delivering it globally will be the next big challenge. To help with that, we have invested the equivalent of £330 million a year for the next five years in GAVI, the global vaccine alliance that delivers vaccines in 68 of the poorest countries around the world. On 4 June, the UK will be hosting the global vaccine summit to co-ordinate international investment efforts for GAVI. Together with the announcement made by the Prime Minister on Monday, that is a combined additional investment in global health security that comes to more than £2 billion, helping combat the spread of disease. In investing globally, we are helping to protect our citizens—our families—from future waves of infection, and protecting our NHS.
The global pandemic is one part of the challenge facing the world. DFID’s immediate coronavirus response to date amounts to £744 million. But this is on top of our work to pivot much of our existing work to provide health, humanitarian and economic support where it is needed most, as part of our response to these crises, with a health response that builds on the UK’s long-standing record of supporting countries to prepare for and respond to large disease outbreaks, including as the third largest donor to the World Health Organisation. We are investing on the frontier of research into new rapid diagnostics and therapeutics that can detect and treat coronavirus. Working in partnership with Unilever, we have launched an innovative hand-washing campaign that will reach 1 billion people around the world—a major contribution to global sanitation and hygiene. With the support of British and international non-governmental organisations, and advice from the London School of Hygiene and Tropical Medicine, we will reach one in seven people around the world with information on the most effective ways to stop the virus spreading and save lives.
We are also working to reduce the global economic impact of the virus by preventing its spread, protecting both the UK public and the stability of our economy. Last month, the UK, together with other G20 countries, announced a commitment to suspend debt service payments to the poorest countries until the end of 2020. This will create up to $12 billion of additional fiscal space. DFID has also made up to £150 million available to the International Monetary Fund for debt relief. These measures will enable developing countries to direct greater domestic resources to their own healthcare efforts, helping to prevent the virus from spreading around the world. We are supporting developing country Governments to make proportionate, evidence-based trade-offs between containing the virus and maintaining open trade, so that essential goods and services, including critical medical and food supplies, can continue to move around the world. That supports developing countries, but it also means that British consumers will get the vital goods they need.
Covid-19 is a global pandemic. It does not respect national borders. Individual efforts will succeed only as part of a global response. The UK will continue to play a leading role in galvanising the most effective co-ordinated international action. In 2017, the scientific community in the UK proudly played a key role in the international response to the Ebola outbreak in west Africa. I am proud to update the House that we are doing so again.
We are using British expertise and funding to demonstrate leadership internationally. Recognising that needs will be great, we are doing whatever it takes to ensure that vaccines, treatments and technologies are available, to save lives and to support economies in the most vulnerable countries, and to help end the pandemic. That will help reduce the risk of the world being attacked by a second wave of infection. As the Prime Minister said on Monday:
“It’s humanity against the virus—we are in this together, and together we will prevail.”
I commend this statement to the House.
Wherever we look, the virus has hit the poorest and most vulnerable hardest and has exacerbated existing inequalities. I am sure the Secretary of State will agree that ensuring that we have a strong, independent DFID is vital to overcoming the immediate emergency of the coronavirus while continuing to tackle global poverty, inequality and the climate crisis.
I support the Secretary of State’s commitment to the pledging event on Monday, which was hosted by the European Union and other partners. I welcome the UK’s commitment of £388 million. Can she tell the House how much of that is new, additional money? Without global collaboration, there is a risk of a scramble between countries, huge price hikes and restrictions on supply, which will all come at the expense of people’s lives. What steps is she taking to secure buy-in from those who did not attend the event and those who did not contribute, such as the United States and China?
Following the comments by the Secretary of State for Health and Social Care about an upside of being first to discover a vaccine, has the International Development Secretary explained to him that creating division and competition between nations will cost lives? Will she also detail the concrete conditions that the Government are attaching to public money going to researching and manufacturing tests, vaccines and medical tools for covid-19, so that those who need access to that vital equipment and medicine are able to access it as quickly as possible wherever they are in the world?
I would also like to take this opportunity to raise the issue of shipments and distribution. Since the week of 22 March, UNICEF has reported a 70% to 80% reduction in planned vaccine shipments. With the huge increase in the cost of flights to deliver goods, what steps is the Secretary of State taking to get medical supplies to countries that are running out and to stop airline companies profiteering from the global pandemic?
I welcome the steps that the International Monetary Fund and the G20 have taken so far on debt relief. The Jubilee Debt Campaign estimates that bonds and other private external debt payments for 77 of the poorest countries will total at least $9.4 billion from May to December 2020. With the UK playing its part as a key jurisdiction for international debt contracts, can the Secretary of State explain what legislative options she is exploring to protect countries from being crippled by private debt?
Coronavirus is not just a health emergency; it is an economic and social one too. These secondary impacts of the coronavirus risk doing untold damage to people’s lives. We already see large-scale food insecurity, increases in deaths due to other health problems such as HIV and malaria, and clampdowns on human rights. The Secretary of State mentioned pivoting resources towards covid-19. Does she agree that diverting resources risks a spike in problems in other areas, as we have already seen in the United Kingdom?
Finally, as we saw during the Ebola outbreak, trusted organisations rooted in communities will be crucial to delivering accurate public health messaging and WASH—water, sanitation and hygiene—projects which save lives. There is no substitute for the unique experiences, relationships and specialisms of local and national civil society organisations. They will be vital to tackling the global pandemic. The latest Bond survey found that 52% of small NGOs have had to cut back on programming working across the global south, removing the lifesaving work they do. I am concerned by how little UK aid has gone to local organisations. Will the Secretary of State ensure that any new plan her Department is involved in, including any revised UN global humanitarian response plan, contains a genuine commitment to scaling up a locally led approach, including women and girls’ rights organisations, large and small INGOs, faith groups and trade unions? As ever, I am here to support and assist.
On funding allocation, we have so far committed £276 million for resilience, with multinational organisations and UN appeals alongside the International Red Cross and the Unilever project. Some £380 million is focused on the vaccine, drugs and therapeutics space through CEPI, FIND—the Foundation for Innovative New Diagnostics—Wellcome and so on, alongside the economic response with the IMF commitment of £150 million and the Gavi investment, which will all be part of the delivery of the vaccine.
I was not aware of the UNICEF statistics on vaccine treatment numbers that the hon. Lady raised, so I will ask my officials to get in touch with her and look closely at that. I thank her for raising that issue with me today.
The event on Monday was co-ordinated by the EU and co-hosted by a number of leaders, including our own Prime Minister. It was a coalition of the willing: a gathering together of those, mostly European, nations who wanted to show their support and solidarity on the international front. We are working closely with the USA on vaccines and more widely on delivery. That continues separately. The USA’s commitment is enormous, and not just internally. I was talking with the new United States Agency for International Development chief, John Barsa earlier in the week about how they are going to focus in the medium term on the substantial commitment the US always makes to supporting vulnerable countries. That will be an ongoing conversation and I think the commitment from USAID is unstinting in that space.
The hon. Lady raised the very important issue of how the conditions go with the funding we put in. That is why we have invested our funds through CEPI and FIND. Both organisations put their money into appropriate projects with an understanding and a contractual relationship that ensures that those scientific programmes will then be accessible to all. It is a really important and secure way—if that is the right way to describe it—of ensuring that UK taxpayers’ money really does reach vulnerable countries when the technologies are discovered.
I completely agree with the hon. Lady on food insecurity. This is absolutely a critical question that we must not lose sight of as we are fighting this disease in the short term. The impact on the most vulnerable countries of food insecurity has not gone away. The threat of locust plagues in just one part of the globe is one critical function we need to get on top of. We are starting to see, as everyone looks up from their own domestic challenges, the great challenge that we have. If we do not support tackling all the other critical preventable death areas, we will find that we cannot tackle this disease. As I said earlier, no one is safe until we are all safe.
The warnings about the impact of covid-19 on the world’s poorest, most vulnerable people have been clear: uncontrolled spread of the virus to fragile states and in refugee camps; a famine of biblical proportions and worldwide economic devastation, resulting in 30 years of the UK’s international development work being undone. However, if we do not tackle covid everywhere, we face the prospect of the infection returning to the UK in a mutated form. What specific measures, beyond aid, are the Government taking to ensure that we tackle covid everywhere? For example, will postponing debt repayments for developing countries be extended beyond 2020, until we know that covid has been eradicated, and will private creditors and multilateral institutions be included in that? What specific public health expertise and medical equipment will be provided to developing countries, and how will wide-scale vaccination programmes be rolled out in countries in conflict, such as Yemen and Syria?
The hon. Gentleman asked about debt relief and the work that has been pulled together by the World Bank and the IMF. We have been an integral part of the conversation, as an important member of those organisations. This is very much a rolling activity. Countries are working on building up country plans and sharing those with the World Bank to understand how, as a whole, the economic community can best support the countries we are talking about to move forward. To answer the question about 2020, there is not an answer as yet, because it is a continuing and rolling conversation with each country, led by the World Bank.
We are looking across our portfolio of programme activity, much of which is in the humanitarian space and in the refugee camps, to make sure that we can repurpose and refocus the work we are doing in the short term, so that we do all we can to get the best healthcare outcomes possible in each of those programme areas.
In terms of delivering vaccines, we are committed to investing in Gavi, because it has both the delivery programme and the respect of so many countries around the globe. Those countries in most conflict will challenge us all, but an organisation such as Gavi, with the support of other UN agencies, is the most effective chance we have to ensure that everybody is vaccinated.
“menacing the whole of humanity—and so the whole of humanity must fight back.”
Without an immediate global response, the world risks up to 1 billion people getting covid-19 infections, and millions of deaths in fragile states and developing countries. Time is running out. What further action—on top of what the Secretary of State has said—will the UK Government take to lead the global effort for a global economic and humanitarian response before the situation becomes catastrophic?
On resuming, the House entered into hybrid substantive proceedings (Order, 22 April).
[NB: [V] denotes a Member contributing virtually.]
Motion made,
The Speaker declared the Question to be agreed to (Order (4), 22 April).
Contains Parliamentary information licensed under the Open Parliament Licence v3.0.